(Q52874727)

9 May 2018

title

Metformin Causes a Reduction in Basal and Post-venous Occlusion Plasminogen Activator Inhibitor-1 in Type 2 Diabetic Patients (English)

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

5 November 2022

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1713132

5 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

5 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

5 November 2022

author name string

P. J. Grant

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1713132

5 November 2022

M. H. Stickland

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1713132

5 November 2022

N. A. Booth

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1713132

5 November 2022

C. R. Prentice

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1713132

5 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1713132

5 November 2022

publication date

1 May 1991

1 reference

9 May 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-5491.1991.tb01610.x

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.1991.tb01610.x/fullpdf

5 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

5 November 2022

1 reference

9 May 2018

volume

8

1 reference

9 May 2018

issue

4

1 reference

9 May 2018

page(s)

361-365

1 reference

9 May 2018

Metformin revisited: its actions and indications for use.

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

FIBRINOLYTIC EFFECT OF METFORMIN IN CORONARY-ARTERY DISEASE

5 November 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity

5 November 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus

5 November 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells

5 November 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

Fibrinolysis and atherosclerosis

5 November 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

The Measurement of Haemoglobin A1c by isoelectric focussing in diabetic patients

5 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

Measurement of fibrinolytic capacity by the euglobulin lysis time method - A problem of “units”

5 November 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

[Rapid physiological coagulation method in determination of fibrinogen]

5 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

Measurement in human blood of fibrinogen/fibrin fragments containing the B beta 15-42 sequence

5 November 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

Plasminogen activator inhibitor (PAI-1) in plasma and platelets

5 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor

5 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

Pre-operative identification of patients at high risk of deep venous thrombosis after elective major abdominal surgery

5 November 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

5 November 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

Haemostatic function and cardiovascular death: early results of a prospective study

5 November 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

Effect of biguanides and atromid on fibrinolysis

5 November 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

Metformin enhances certain insulin actions in cultured rat hepatoma cells

5 November 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01610.X

5 November 2022

Identifiers

1 reference

9 May 2018

1 reference

9 May 2018